Atlas Trials

Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT

Clinical trial NCT05938478 · RECRUITING

Trial details

NCT number
NCT05938478
Sponsor
University of California, San Diego
Status
RECRUITING
Study type
OBSERVATIONAL
Atopic DermatitisEczema
Start date
2022-12-08
Primary completion
2034-11-30
Enrollment
900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.